Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

BATM Advanced Communications / Equity Bottom-Up

<ul>
<li>The transitioning and rebranded provider of advanced network infrastructure, cybersecurity, and diagnostic technologies reported interims to end June on the 18 August.</li>
<li>The business is concentrating on three core businesses: BATM Networks, BATM Cyber and BATM Diagnostics.</li>
<li>Substantial operational changes have been implemented, and non-core activities are being sold with three disposals made in the first half of 2025.</li>
</ul>


The transitioning and rebranded provider of advanced network infrastructure, cybersecurity, and diagnostic technologies reported interims to end June on the 18 August.
The business is concentrating on three core businesses: BATM Networks, BATM Cyber and BATM Diagnostics.
Substantial operational changes have been implemented, and non-core activities are being sold with three disposals made in the first half of 2025.


<ul>
<li>A provider to international blue-chip clients of real-time innovative technologies focusing on core activities in Cyber Business, Networking and Diagnostics.</li>
<li>The published trading update, with its backdrop of divestment and macroeconomic conditions, paved the way for disappointing finals.</li>
<li>These reported a marginal increase in total revenue to $117.3m, with stronger growth in the Cyber and Diagnostics divisions offsetting lower revenues in the Networking division. </li>
</ul>


A provider to international blue-chip clients of real-time innovative technologies focusing on core activities in Cyber Business, Networking and Diagnostics.
The published trading update, with its backdrop of divestment and macroeconomic conditions, paved the way for disappointing finals.
These reported a marginal increase in total revenue to $117.3m, with stronger growth in the Cyber and Diagnostics divisions offsetting lower revenues in the Networking division. 


BATM Advanced Communications Ltd - Friday Take Away: 21 March 2025

<ul>
<li>BATM Advanced Communications 14.7p £64m (BVC.L) The real-time technologies for networks and cyber solutions and medical laboratory systems Company announces its FY results for December 2024.</li>
<li>A marginal increase in total revenue to $117.3m was achieved, with strong growth in the Cyber and Diagnostics divisions offsetting lower revenues in the Networking division.</li>
<li>The Adjusted Profit Before Tax was $3m, down from $5.9m for FY 2023, and Cash and short-term investments were $31.6m (30 June 2024: $32.6m). </li>
</ul>


BATM Advanced Communications 14.7p £64m (BVC.L) The real-time technologies for networks and cyber solutions and medical laboratory systems Company announces its FY results for December 2024.
A marginal increase in total revenue to $117.3m was achieved, with strong growth in the Cyber and Diagnostics divisions offsetting lower revenues in the Networking division.
The Adjusted Profit Before Tax was $3m, down from $5.9m for FY 2023, and Cash and short-term investments were $31.6m (30 June 2024: $32.6m). 


BATM Advanced Communications Ltd - Hybridan Small Cap Feast: 17/03/2025

<ul>
<li>The provider of real-time technologies for networking solutions and medical laboratory systems updated on trading for YE December 2024 and its strategy.</li>
<li>The broad strategy is to focus on its core strengths of cyber security, networks and diagnostics, and to dispose of non-core assets.</li>
<li>It continues to explore potential M&amp;A opportunities and to divest its non-core businesses. Its first disposal is Progenetics, a non-core asset, for approximately $2m in cash for its 51% shareholding. </li>
</ul>


The provider of real-time technologies for networking solutions and medical laboratory systems updated on trading for YE December 2024 and its strategy.
The broad strategy is to focus on its core strengths of cyber security, networks and diagnostics, and to dispose of non-core assets.
It continues to explore potential M&amp;A opportunities and to divest its non-core businesses. Its first disposal is Progenetics, a non-core asset, for approximately $2m in cash for its 51% shareholding. 


Cross Asset Strategy

<ul>
<li>Following the £2m fund raise on 4 July 2025 at 0.3p, it’s been a busy two months.</li>
<li>The announcements in August include a paid contract extension with a global partner, an update on licensing opportunities, and a new Biomarker Discovery service launch.</li>
<li>Aptamer is a life science Company developing customised affinity binders through its proprietary Optimer platform which enables clients to take new approaches in therapeutics, diagnostics, and research applications. </li>
</ul>


Following the £2m fund raise on 4 July 2025 at 0.3p, it’s been a busy two months.
The announcements in August include a paid contract extension with a global partner, an update on licensing opportunities, and a new Biomarker Discovery service launch.
Aptamer is a life science Company developing customised affinity binders through its proprietary Optimer platform which enables clients to take new approaches in therapeutics, diagnostics, and research applications. 


United Kingdom

BATM Advanced Communications Ltd. develops real-time technologies for networking, cyber, and bio-medical applications. The Company provides products and services for carrier ethernet, NFV, and cyber network monitoring for a wide area networks, as well as for medical diagnostic solutions, bio-waste treatment and sterilisation, and distribution of third-party medical supplies.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

BATM Advanced Communications (BVC LN)

Friday Take Away: 22 August 2025

The transitioning and rebranded provider of advanced network infrastructure, cybersecurity, and diagnostic technologies reported interims to end...

Hybridan

BATM Advanced Communications Ltd - Friday Take Away: 21 March 2025

A provider to international blue-chip clients of real-time innovative technologies focusing on core activities in Cyber Business, Networking and...

Hybridan

BATM Advanced Communications Ltd - Hybridan Small Cap Feast: 17/03/2025

The real-time technologies for networks and cyber solutions and medical laboratory systems Company announces its FY results for December 2024.

Hybridan

Hybridan Small Cap Feast: 05/03/2025

The provider of real-time technologies for networking solutions and medical laboratory systems updated on trading for YE December 2024 and its...

Hybridan

Friday Take Away: 29 August 2025

The announcements in August include a paid contract extension with a global partner, an update on licensing opportunities, and a new Biomarker...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)